Sunder Biomedical Tech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sunder Biomedical Tech Co Ltd

Watchlist Manager

Watchlist

Price: 7.69 TWD Market Closed

Market Cap: NT$461.4m

S	Sunder Biomedical Tech Co Ltd TPEX:4115	TW
	Mount Logan Capital Inc OTC:PYCFF	CA

Profitability Summary

Sunder Biomedical Tech Co Ltd's profitability score is 41/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

15%

Sustainable 3Y Average Gross Margin

15%

Gross Margin is Increasing

8% > 15%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

Operating Margin is Increasing

-5% > -1%

Negative Net Margin

-1%

Low 3Y Average Net Margin

Net Margin is Increasing

-5% > -1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

ROIC is Increasing

-3% > -1%

View All

Hide

Collapse

41 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

15%

Sustainable 3Y Average Gross Margin

15%

Gross Margin is Increasing

8% > 15%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

Operating Margin is Increasing

-5% > -1%

Negative Net Margin